ALT - Altimmune - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ALT is currently covered by 2 analysts with an average price target of $18. This is a potential upside of $20.15 (445.45%) from yesterday's end of day stock price of $3.3.

Altimmune's activity chart (see below) currently has 82 price targets and 83 ratings on display. The stock rating distribution of ALT is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 14.55% with an average time for these price targets to be met of 52 days.

Highest price target for ALT is $25, Lowest price target is $11, average price target is $18.

Most recent stock forecast was given by from JMP on 14-May-2026. First documented stock forecast 27-Nov-2017.

Currently out of the existing stock ratings of ALT, 5 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 28-Jul-2020

$11

$8.18 (290.07%)

$14

4 months ago
(14-May-2026)

0/18 (0%)

$8.08 (276.71%)

Buy Since 02-Jun-2021

$25

$22.18 (786.52%)

$12

5 months 29 days ago
(16-Mar-2026)

0/25 (0%)

$21.38 (590.61%)

Buy Since 12-Nov-2024

$24

$21.18 (751.06%)

$26

1 years 1 months 1 days ago
(13-Aug-2025)

0/3 (0%)

$20.26 (541.71%)

Buy Since 25-Sep-2020

$18

$15.18 (538.30%)

$20

1 years 1 months 1 days ago
(13-Aug-2025)

3/14 (21.43%)

$14.26 (381.28%)

272

Buy Since 01-Jun-2020

$25

$22.18 (786.52%)

$25

2 years 2 months 24 days ago
(21-Jun-2024)

1/14 (7.14%)

$18.59 (290.02%)

37

Show more analysts

Please expand the browser size to see the chart

What is ALT (Altimmune) average time for price targets to be met?

On average it took 52 days for the stock forecasts to be reached, with an average price target met ratio of 14.55%.

Which analyst most recently updated their price target on ALT (Altimmune)?

Which analyst has the most public recommendations on ALT (Altimmune)?

has 0 price targets and 0 ratings on ALT

Which analyst is the currently most bullish on ALT (Altimmune)?

Gal Munda with the highest potential upside of $66.76

Which analyst is the currently most reserved on ALT (Altimmune)?

Kelechi Chikere with the lowest potential downside of -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?